| 1 |
1993 |
Scheveningen |
M. Wilkinson |
Medication misuse headache |
| 2 |
1994 |
Arundel |
L.A.H. Hogenhuis |
Headache and the interganglionic circuitry |
| 3 |
1995 |
Apeldoorn |
J.M.S. Pearce |
Headaches and diagnoses |
| 4 |
1996 |
Mildenhall |
G.W. Bruyn |
Migraine. A Head in digression |
| 5 |
1997 |
’s Hertogenbosch |
J.D. Carroll |
Through the looking glass |
| 6 |
1998 |
Durham |
P. Saxena |
Migraine and serotonine |
| 7 |
1999 |
Leiden |
J.N. Blau |
Migraine is solvable - but how? |
| 8 |
2000 |
Edinburgh |
P.J. Koehler |
Headache history & history of headache. A day on “Cephamal Farm” |
| 9 |
2001 |
Utrecht |
M. Sandler |
Biochemical aspects of migraine |
| 10 |
2002 |
Warwick |
J.W. Hartma
n |
Question marks |
| 11 |
2003 |
Rotterdam |
E.A. MacGregor |
The problem with women |
| 12 |
2004 |
Chester |
A. Keyser |
Migraine after 400 years, a clinician’s view |
| 13 |
2005 |
Nijmegen |
T.J. Steiner |
WHO cares about headache. The Burden of Headache |
| 14 |
2006 |
Exeter |
J.L. van der Zwan |
Chocolate, craving and triggering |
| 15 |
2007 |
Leuven |
R. Cull |
The Art of Migraine Genetics |
| 16 |
2008 |
Buxton |
M.J. Sorbi |
Behaviour counts in migraine prophylaxis |
| 17 |
2009 |
Amsterdam |
R. Peatfield |
Has headache any purpose? |
| 18 |
2010 |
London |
J. Haan |
The art of Migraine Painting & Genetics |
| 19 |
2011 |
Maastricht |
P. Davies |
|
| 20 |
2012 |
Brighton |
Antoinette Maassen van den Brink |
Blood vessels and migraine; from organ bath to woman |
| 21 |
2013 |
Haarlem |
Manjit Matharu |
Cervicogenic headache |
| 22 |
2014 |
Greenwich |
Wim Mulleners |
Cortical dysexcitability in migraine: science and semantics |
| 23 |
2015 |
Valencia |
Professor Alan Rapoport |
From an American point of view |
| 24 |
2016 |
Dordrecht |
Zameel Cader |
Novel tools and technologies to solve the mysteries of migraine |
| 25 |
2017 |
Norwich |
Gisela Terwindt |
Let's talk about genetics! |
| 26 |
2018 |
Zwolle |
Dr Alexandra Sinclair |
Idiopathic Intracranial Hypertension: From pathogenic underpinnings & novel therapeutics to management guidelines |